India allows exports of anti-malaria drug
April. 07, 2020
India will allow some exports of the anti-malaria drug hydroxychloroquine after US President Donald Trump urged New Delhi to release supplies of the drug seen as a possible treatment for COVID-19.
The Indian government had earlier put a hold on exports of hydroxychloroquine as well as on the pain reliever, paracetamol, saying it had to meet its internal demand.
But Trump spoke to Prime Minister Narendra Modi over the weekend seeking supplies and later hinted that India may face retaliation.
"It has been decided that India would licence paracetamol and HCQ in appropriate quantities to all our neighbouring countries who are dependent on our capabilities," said Indian foreign ministry spokesman, Anurag Srivastava.
"We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic," he said.
Vera Omozuwa: UNIBEN reacts to alleged rape of 100 level student in churchPremier League clubs set for friendlies after being given go-aheadGeorge Floyd: FIFA releases statement on players demanding justice for late AmericanBuhari to address small businesses at 2020 MSMEs awardsHausa needs to join Biafra, Oduduwa Republic to secede from Nigeria – Nnamdi Kanu